Cambridge Investment Research Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-949
Closed -$270K 4035
2025
Q4
$270K Sell
949
-1,420
-60% -$444K ﹤0.01% 3301
2025
Q3
$731K Buy
2,369
+579
+32% +$181K ﹤0.01% 2313
2025
Q2
$562K Buy
1,790
+607
+51% +$175K ﹤0.01% 2433
2025
Q1
$311K Sell
1,183
-1,017
-46% -$275K ﹤0.01% 2838
2024
Q4
$574K Sell
2,200
-1,263
-36% -$318K ﹤0.01% 2304
2024
Q3
$806K Sell
3,463
-568
-14% -$117K ﹤0.01% 2026
2024
Q2
$813K Sell
4,031
-235
-6% -$42.3K ﹤0.01% 1920
2024
Q1
$731K Sell
4,266
-3,482
-45% -$649K ﹤0.01% 1958
2023
Q4
$1.68M Buy
7,748
+4,724
+156% +$810K 0.01% 1314
2023
Q3
$482K Buy
3,024
+466
+18% +$104K ﹤0.01% 2119
2023
Q2
$738K Sell
2,558
-977
-28% -$297K ﹤0.01% 1834
2023
Q1
$1.13M Sell
3,535
-723
-17% -$214K 0.01% 1497
2022
Q4
$1.25M Sell
4,258
-437
-9% -$121K 0.01% 1363
2022
Q3
$1.08M Sell
4,695
-1,110
-19% -$278K 0.01% 1421
2022
Q2
$1.26M Buy
5,805
+547
+10% +$124K 0.01% 1304
2022
Q1
$1.4M Sell
5,258
-361
-6% -$88.6K 0.01% 1356
2021
Q4
$1.5M Sell
5,619
-130
-2% -$37.7K 0.01% 1323
2021
Q3
$1.63M Buy
5,749
+66
+1% +$18.8K 0.01% 1215
2021
Q2
$1.56M Buy
5,683
+1,358
+31% +$369K 0.01% 1248
2021
Q1
$1.13M Buy
4,325
+2,376
+122% +$636K 0.01% 1351
2020
Q4
$498K Buy
1,949
+709
+57% +$176K ﹤0.01% 1768
2020
Q3
$293K Sell
1,240
-461
-27% -$97.1K ﹤0.01% 1951
2020
Q2
$330K Buy
+1,701
New +$325K ﹤0.01% 1814

Other funds holding PODD

Cambridge Investment Research Advisors's PODD Position: Q1 2026 in Review

Cambridge Investment Research Advisors sold out of Insulet (PODD) in Q1 2026, closing a stake of 949 shares — an estimated $270K sold.

Cambridge Investment Research Advisors first reported a position in PODD in Q2 2020 and held it in 23 quarters. The position peaked at $1.68M in Q4 2023. 787 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Cambridge Investment Research Advisors reported no remaining Insulet position as of Q1 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 949 Insulet shares in Q1 2026, an estimated $270K.
  • Cambridge Investment Research Advisors first reported a position in Insulet in Q2 2020 and held it in 23 quarters.
  • Cambridge Investment Research Advisors's Insulet position peaked at $1.68M in Q4 2023.
  • 787 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.